MedPath
TGA Approval

Aldazide (Spironolactone 25mg, Buthiazide 2.5mg) tablets (33606)

33606

Aldazide (Spironolactone 25mg, Buthiazide 2.5mg) tablets

Proqualix Pty Ltd - in Administration

November 7, 1991

Medicine

Medicine

Active

Listed - Exempt

Active Ingredients

butizide

spironolactone

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Aldazide (Spironolactone 25mg, Buthiazide 2.5mg) tablets (33606) - TGA 批准文号 | MedPath